Brief: Kazia Regains Compliance With Nasdaq Minimum Bid Price Requirement
14/04/2023 12:13
April 14 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* KAZIA REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE
REQUIREMENT
Source text for Eikon: ID:nPn9kR7YGa
Further company coverage: KZA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt